[1]赵瑞强,温　燕,廖　燕,等.细胞周期蛋白E1基因rs1406（G/T）位点多态性与肝细胞癌高发家系遗传易感性的相关性[J].新乡医学院学报,2020,37(4):337-341.[doi:10.7683/xxyxyxb.2020.04.008]
　ZHAO Ruiqiang,WEN Yan,LIAO Yan,et al.Relationship between polymorphism at rs1406 (G/T) locus of cyclin E1 gene and genetic susceptibility of hepatocellular carcinoma high-incidence family[J].Journal of Xinxiang Medical University,2020,37(4):337-341.[doi:10.7683/xxyxyxb.2020.04.008]
点击复制

细胞周期蛋白E1基因rs1406（G/T）位点多态性与肝细胞癌高发家系遗传易感性的相关性
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年4
页码:
337-341
栏目:
临床研究
出版日期:
2020-04-05

文章信息/Info

Title:
Relationship between polymorphism at rs1406 (G/T) locus of cyclin E1 gene and genetic susceptibility of hepatocellular carcinoma high-incidence family
作者:
赵瑞强1; 2; 温　燕3; 廖　燕4; 谢裕安2
（1.广西医科大学基础医学院，广西　南宁　530021； 2.广西医科大学附属肿瘤医院实验研究部，广西　南宁　530021；3.广西医科大学第一附属医院药学部，广西　南宁　530021；4.南宁市第二人民医院输血科，广西　南宁　530031）
Author(s):
ZHAO Ruiqiang1; 2; WEN Yan3; LIAO Yan4; XIE Yu′an2
（1.The School of Prechinical Medicine of Guangxi Medical University,Nanning 530021,Guangxi Province,China；2.Department of Experimental Research,the Affiliated Tumor Hospital of Guangxi Medical University,Nanning 530021,Guangxi Province,China;3.Department of Pharmacy,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,Guangxi Province,China;4.Department of Blood Transfusion,the Second People′S Hospital of Nanning City,Nanning 530031,Guangxi Province,China）
关键词:
肝细胞癌; 细胞周期蛋白E1; 单核苷酸多态性; 遗传易感性
Keywords:
hepatocellular carcinoma; cyclin E1; single nucleotide polymorphism; genetic susceptibility
分类号:
R735.7
DOI:
10.7683/xxyxyxb.2020.04.008
文献标志码:
A
摘要:
目的　探讨细胞周期蛋白E1（CCNE1）基因rs1406（G/T）位点多态性与肝细胞癌高发家系遗传易感性的关系。方法　选择2003年1月至2011年10月广西扶绥县壮族肝细胞癌高发地区20个肝细胞癌家系，包括肝细胞癌患者20例(A组)及其直系亲属59例(B组)；另选10个生活在同一地区的正常家系（共40例）作为对照(C组)。各家系均符合Hardy-Weinberg遗传平衡，具有人群代表性。利用质谱方法检测CCNE1基因rs1406(G/T)位点基因型分布频率；采用PLINK软件分析各家系人群基因型分布频率差异。结果　CCNE1基因rs1406（G/T）位点存在GG、TT、GT 3种基因型。A组GG基因型3例，TT基因型3例，GT基因型14例； B组GG基因型14例，TT基因型14例，GT基因型31例； C组GG基因型23例，TT基因型2例，GT基因型15例。A组与B组人群CCNE1 rs1406（G/T）位点上G、T分布频率比较差异无统计学意义（P>0.05）。A+B组与C组人群rs1406（G/T）等位基因G、T分布频率比较差异有统计学意义（比值比=3.639，95%可信区间：1.533~8.637,P＜0.05）。结论　CCNE1基因rs1406 (T)为广西扶绥县壮族人群肝细胞癌发生的风险基因型。
Abstract:
Objective　To investigate the relationship between polymorphism at rs1406(G/T) locus of cyclin E1（CCNE1） gene and genetic susceptibility of hepatocellular carcinoma high-incidence family.Methods　Twenty hepatocellular carcinoma families in high-incidence area of Zhuang people in Fusui county of Guangxi province were selected from January 2003 to October 2011,including 20 hepatocellular carcinoma patients (group A) and 59 immediate family members of the patients(group B).Another 10 normal families including 40 healthy people who lived in the same area were selected as control(group C).All families were compatible with Hardy-Weinberg genetic equilibrium,and were representative of the population.The genotype distribution frequency of rs1406 (G/T) locus in CCNE1 gene was detected by mass spectrometry.The differences in genotype distribution frequency among all families were analyzed by using PLINK software.Results　There were three genotypes of GG,TT and GT in rs1406 (G/T) locus of CCNE1 gene.There were 3 cases of GG genotype,3 cases of TT genotype and 14 cases of GT genotype in group A；there were 14 cases of GG genotype,14 cases of TT genotype and 31 cases of GT genotype in group B；and there were 23 cases of GG genotype,2 cases of TT genotype and 15 cases of GT genotype in group C.There was no significant difference in the distribution frequency of G and T alleles at rs1406 (G/T) locus of CCNE1 gene between the group A and group B (P>0.05).There was significant difference in the distribution frequency of G and T alleles at rs1406 (G/T) locus of CCNE1 gene between the group (A+B) and group C (odd ratio= 3.639,95% confidence interval was 1.533-8.637,P<0.05).Conclusion　The rs1406 (T) of CCNE1 gene is the risk genotype for hepatocellular carcinoma in Zhuang people in Fusui County,Guangxi province.

参考文献/References:

［1］　陈万青，孙可欣，郑荣寿，等.2014年中国分地区恶性肿瘤发病和死亡分析［J］.中国肿瘤,2018,27(1):1-14.
［2］　何明荣.广西扶绥县2009年恶性肿瘤发病分析［J］.中国肿瘤,2013(12):1001-1005.
［3］　TORRE L A,BRAY F,SIEGEL R L,et al.Global cancer statistics,2012［J］.CA Cancer J Clin,2015,65(2):87-108.
［4］　米登海，罗好曾，陈学鹏，等.肝癌遗传模式与危险因素病例-对照研究［J］.中国公共卫生,2006(7):849-850.
［5］　SYVANEN A C.Accessing genetic variation：genotyping single nucleotide polymorphisms［J］.Nat Rev Genet,2001,2(12):930-942.
［6］　ZSCHEMISCH N H,LIEDTKE C,DIERSSEN U,et al.Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo［J］.Hepatology,2006,44(1):164-173.
［7］　JIANG W,HUANG H,DING L,et al.Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability［J］.Oncogene,2015,34(34):4460-4470.
［8］　CHEN M J,CHENG A C,LEE M F,et al.Simvastatin induces G1 arrest by up-regulating GSK3beta and down-regulating CDK4/cyclin D1 and CDK2/cyclin E1 in human primary colorectal cancer cells［J］.J Cell Physiol,2018,233(6):4618-4625.
［9］　OOI A,OYAMA T,NAKAMURA R,et al.Gene amplification of CCNE1,CCND1,and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization［J］.Hum Pathol,2017,61:58-67.
［10］　YAO Y,LUO J,SUN Q,et al.HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1［J］.Am J Cancer Res,2017,7(9):1820-1834.
［11］　LU Y,LI W.Functional characterization of E2F3b in human HepG2 liver cancer cell line［J］.J Cell Biochem,2018,119(4):3429-3439.
［12］　YANG H,ZHANG X,CAI X Y,et al.From big data to diagnosis and prognosis：gene expression signatures in liver hepatocellular carcinoma［J］.Peer J,2017,5（10）:e3089.
［13］　LEFKOWITCH J H,LAGANA S M,KATO T.Hepatocellular carcinoma in noncirrhotic liver with glycogenotic foci：basic science meets genomic medicine［J］.Semin Liver Dis,2015,35(4):450-456.
［14］　GABA R C,GROTH J V,PARVINIAN A,et al.Gene expression in hepatocellular carcinoma：pilot study of potential transarterial chemoembolization response biomarkers［J］.J Vasc Interv Radiol,2015,26(5):723-732.
［15］　LI W,ZENG X,LEE N P,et al.HIVID：an efficient method to detect HBV integration using low coverage sequencing［J］.Genomics,2013,102(4):338-344.
［16］　祝葆华,王兰天,李涛,等.HBsAg阳性肝癌细胞基因组中HBx相关整合位点的探讨［J］.中华肝脏病杂志,2012,20(6)：468-471.
［17］　SUNG W K,ZHENG H,LI S,et al.Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma［J］.Nat Genet,2012,44(7):765-769.
［18］　EHEDEGO H,MOHS A,JANSEN B,et al.Loss of cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury［J］.Oncogene,2018，37(25):3329-3339.
［19］　赵辉，王威，张清润，等.高通量飞行时间质谱基因分型方法的研究［J］.生物化学与生物物理进展,2005(7):667-672.
［20］　LIU X,HE M,HOU Y,et al.Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma［J］.Oncol Rep,2013,29(4):1415-1420.
［21］　WANG J Y,JIANG J B,LI Y,et al.MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma［J］.Biomed Pharmacother,2017,93:1047-1054.
［22］　ZHENG D,DAI Y,WANG S,et al.MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1［J］.Int J Clin Exp Pathol,2015,8(9):10072-10081.
［23］　HE H,WANG L,ZHOU W,et al.MicroRNA expression profiling in clear cell renal cell carcinoma：identification and functional validation of key miRNAs［J］.PLoS One,2015,10(5):e125672.
［24］　JUNG Y J,LEE K H,CHOI D W,et al.Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma［J］.Cancer Lett,2001,168(1):57-63.
［25］　SPRUCK C H,WON K A,REED S I.Deregulated cyclin E induces chromosome instability［J］.Nature,1999,401(6750):297-300.
［26］　BIAZI B I,ZANETTI T A,BARANOSKI A,et al.Cis-nerolidol induces endoplasmic reticulum stress and cell death in human hepatocellular carcinoma cells through extensive CYP2C19 and CYP1A2 oxidation［J］.Basic Clin Pharmacol Toxicol,2017,121(4):334-341.
［27］　NEVZOROVA Y A,BANGEN J M,HU W,et al.Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice［J］.Hepatology,2012,56(3):1140-1149.
［28］　POK S,WEN V,SHACKEL N,et al.Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis［J］.J Gastroenterol Hepatol,2013,28(9):1545-1554.
［29］　FURUTA M,KOZAKI K,TANIMOTO K,et al.The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma［J］.PLoS One,2013,8(3):e60155.
［30］　ZHANG X,HU S,ZHANG X,et al.MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells［J］.Biochem Biophys Res Commun,2014,443(3):1078-1084.
［31］　LAQUAGLIA M J,GRIJALVA J L,MUELLER K A,et al.YAP subcellular localization and hippo pathway transcriptome analysis in pediatric hepatocellular carcinoma［J］.Sci Rep,2016,6:30238.

相似文献/References:

[1]王建国,聂常富,孔凡明,等.原发性肝癌患者外周血甲胎蛋白mRNA表达水平与临床参数的关系[J].新乡医学院学报,2002,19(04):247.
[2]章弦,周杰.肝移植符合米兰标准和符合杭州标准肝细胞癌患者预后分析[J].新乡医学院学报,2011,28(05):617.
[3]王宇锋,朱怡凤,殷国志.肝细胞癌中microRNA-1469表达及其对肝癌细胞生物学行为的影响[J].新乡医学院学报,2019,36(9):806.[doi:10.7683/xxyxyxb.2019.09.002]
　WANG Yu-feng,ZHU Yi-feng,YIN Guo-zhi.Expression of microRNA-1469 and its function in hepatocellular carcinoma cells[J].Journal of Xinxiang Medical University,2019,36(4):806.[doi:10.7683/xxyxyxb.2019.09.002]
[4]查　青,陈燕妮,晁　旭.土贝母对小鼠肝癌的抑制作用及其机制[J].新乡医学院学报,2021,38(4):301.[doi:10.7683/xxyxyxb.2021.04.001]
　ZHA Qing,CHEN Yanni,CHAO Xu.Inhibitory effect of Tubeimu on hepatocarcinoma in mice and its mechanism[J].Journal of Xinxiang Medical University,2021,38(4):301.[doi:10.7683/xxyxyxb.2021.04.001]
[5]唐灿伟,陈清江,陈菲,等.基于数据库分析脂肪非典型钙黏蛋白1在肝细胞癌中的表达及其临床意义[J].新乡医学院学报,2020,37(10):925.[doi:10.7683/xxyxyxb.2020.10.006]
　TANG Canwei,CHEN Qingjiang,CHEN Fei,et al.Expression and clinical significance of adipose atypical cadherin 1 in hepatocellular carcinoma based on database[J].Journal of Xinxiang Medical University,2020,37(4):925.[doi:10.7683/xxyxyxb.2020.10.006]
[6]金　雯,王　波,杨　梅,等.桩蛋白表达对裸鼠肝癌细胞增殖的影响[J].新乡医学院学报,2019,36(3):224.[doi:10.7683/xxyxyxb.2019.03.005]
　JIN Wen,WANG Bo,YANG Mei,et al.Effect of paxillin expression on proliferation of hepatocellular carcinoma cells in nude mice[J].Journal of Xinxiang Medical University,2019,36(4):224.[doi:10.7683/xxyxyxb.2019.03.005]
[7]张海鹏,鲍启德,周利霞,等.吉非替尼联合奥沙利铂对人肝癌细胞SMMC-7721增殖和凋亡的影响[J].新乡医学院学报,2019,36(12):1115.[doi:10.7683/xxyxyxb.2019.12.004]
　ZHANG Hai-peng,BAO Qi-de,ZHOU Li-xia,et al.Effect of gefitinib combined with oxaliplatin on proliferation and apoptosis of human hepatoma cell SMMC-7721[J].Journal of Xinxiang Medical University,2019,36(4):1115.[doi:10.7683/xxyxyxb.2019.12.004]
[8]柴　婕,冯思佳,崔　静,等.磷脂酸磷酸酶2域1A在不同转移能力肝癌细胞系中的表达[J].新乡医学院学报,2017,34(8):678.[doi:10.7683/xxyxyxb.2017.08.004]
　CHAI Jie,FENG Si-jia,CUI Jing,et al.Expression of phosphatidic acid phosphatase type 2 domain containing 1A in hepatocellular carcinoma cell lines with different metastatic ability[J].Journal of Xinxiang Medical University,2017,34(4):678.[doi:10.7683/xxyxyxb.2017.08.004]
[9]冯超群,郭小亮,李学伦.超声引导下胸椎椎旁神经阻滞复合全身麻醉在肝部分切除术中的应用[J].新乡医学院学报,2016,33(4):308.[doi:10.7683/xxyxyxb.2016.04.015]
　FENG Chao-qun,GUO Xiao-liang,LI Xue-lun.Application of thoracic paravertebral block by ultrasonic guidance combined with general anaesthesia in partial hepatectomy[J].Journal of Xinxiang Medical University,2016,33(4):308.[doi:10.7683/xxyxyxb.2016.04.015]

更新日期/Last Update: 2020-04-05